Aroa Biosurgery Limited (ARX.AX)
AUD 0.7
(2.96%)
AUD 0.7
(2.96%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 | 14.77 Million AUD | 7.97% |
| 2023 | 13.69 Million AUD | 21.15% |
| 2022 | 11.3 Million AUD | -41.83% |
| 2021 | 19.43 Million AUD | -1.24% |
| 2020 | 19.67 Million AUD | -25.58% |
| 2019 | 26.43 Million AUD | 110.93% |
| 2018 | 12.53 Million AUD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q3 | 14.94 Million AUD | 4.03% |
| 2024 Q4 | 14.77 Million AUD | -1.08% |
| 2024 FY | 14.77 Million AUD | 7.92% |
| 2024 Q1 | 14.22 Million AUD | 3.86% |
| 2024 Q2 | 14.36 Million AUD | 1.02% |
| 2023 Q3 | 13.64 Million AUD | 10.72% |
| 2023 FY | 13.69 Million AUD | 21.15% |
| 2023 Q4 | 13.69 Million AUD | 0.36% |
| 2023 Q2 | 12.32 Million AUD | 0.0% |
| 2022 FY | 11.3 Million AUD | -41.83% |
| 2022 Q2 | 10.53 Million AUD | 0.0% |
| 2022 Q4 | 11.3 Million AUD | 0.0% |
| 2021 Q4 | 19.43 Million AUD | 0.0% |
| 2021 FY | 19.43 Million AUD | -1.24% |
| 2021 Q2 | 18.55 Million AUD | 0.0% |
| 2020 FY | 19.67 Million AUD | -25.58% |
| 2020 Q4 | 37.15 Million AUD | 0.0% |
| 2019 FY | 26.43 Million AUD | 110.93% |
| 2018 FY | 12.53 Million AUD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| 4DMedical Limited | 49.08 Million AUD | 69.894% |
| Adherium Limited | 3.4 Million AUD | -333.803% |
| Atomo Diagnostics Limited | 1.29 Million AUD | -1041.742% |
| Anteris Technologies Ltd | 17.03 Million AUD | 13.267% |
| Control Bionics Limited | 2.75 Million AUD | -435.535% |
| CardieX Limited | 8.56 Million AUD | -72.601% |
| Compumedics Limited | 22.14 Million AUD | 33.273% |
| Cochlear Limited | 904.6 Million AUD | 98.366% |
| CleanSpace Holdings Limited | 6.94 Million AUD | -112.651% |
| Cyclopharm Limited | 13.65 Million AUD | -8.231% |
| EMVision Medical Devices Ltd | 5.45 Million AUD | -170.886% |
| Nova Eye Medical Limited | 8.55 Million AUD | -72.809% |
| HeraMED Limited | 1.5 Million AUD | -881.357% |
| Imricor Medical Systems, Inc. | 25 Million AUD | 40.896% |
| ImpediMed Limited | 6.24 Million AUD | -136.723% |
| InhaleRx Limited | 911.41 Thousand AUD | -1521.508% |
| LBT Innovations Limited | 5.5 Million AUD | -168.312% |
| Micro-X Limited | 12.63 Million AUD | -16.975% |
| Neurotech International Limited | 314.69 Thousand AUD | -4596.117% |
| OncoSil Medical Limited | 1.98 Million AUD | -645.645% |
| PolyNovo Limited | 37.04 Million AUD | 60.104% |
| Respiri Limited | 3.55 Million AUD | -315.834% |
| SomnoMed Limited | 24.78 Million AUD | 40.362% |
| Universal Biosensors, Inc. | 10.61 Million AUD | -39.256% |
| Uscom Limited | 2.07 Million AUD | -612.713% |
| Visioneering Technologies, Inc. | 2.76 Million AUD | -434.121% |